BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11525581)

  • 1. Management of acute myeloid leukaemia. A regional audit in the south and west of the United Kingdom.
    Rule S; Poirer V; Singer C
    Clin Med (Lond); 2001; 1(4):313-6. PubMed ID: 11525581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
    Dharmani C; Wang E; Tu N; Salas M; Kamel YM
    Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematologists' approaches to the management of adolescents and young adults with acute leukaemia.
    Benjamin S; Kroll ME; Cartwright RA; Clough JV; Gorst DW; Proctor SJ; Ross JR; Taylor PR; Wheatley K; Whittaker JA; Stiller CA
    Br J Haematol; 2000 Dec; 111(4):1045-50. PubMed ID: 11167738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
    Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
    J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
    Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of acute myeloid leukaemia (AML) in UK: past, present and future.
    Rees JK
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():110-3. PubMed ID: 2653483
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of acute myeloid leukemia in the elderly patient].
    Wedding U; Höffken K
    Z Gerontol Geriatr; 2001 Aug; 34(4):269-76. PubMed ID: 11584711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
    Cortes J; Perl AE; Döhner H; Kantarjian H; Martinelli G; Kovacsovics T; Rousselot P; Steffen B; Dombret H; Estey E; Strickland S; Altman JK; Baldus CD; Burnett A; Krämer A; Russell N; Shah NP; Smith CC; Wang ES; Ifrah N; Gammon G; Trone D; Lazzaretto D; Levis M
    Lancet Oncol; 2018 Jul; 19(7):889-903. PubMed ID: 29859851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
    Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
    Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
    Filì C; Candoni A; Zannier ME; Olivieri J; Imbergamo S; Caizzi M; Nadali G; Di Bona E; Ermacora A; Gottardi M; Facchinelli D; Ciancia R; Lazzarotto D; Dubbini MV; Festini G; Gherlinzoni F; Michieli MG; Semenzato G; Fanin R
    Leuk Res; 2019 Jan; 76():33-38. PubMed ID: 30529681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
    Burnett AK; Russell NH; Kell J; Dennis M; Milligan D; Paolini S; Yin J; Culligan D; Johnston P; Murphy J; McMullin MF; Hunter A; Das-Gupta E; Clark R; Carr R; Hills RK
    J Clin Oncol; 2010 May; 28(14):2389-95. PubMed ID: 20385984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.
    Schnegg-Kaufmann A; Feller A; Baldomero H; Rovo A; Manz MG; Gregor M; Efthymiou A; Bargetzi M; Hess U; Spertini O; Chalandon Y; Passweg JR; Stussi G; Arndt V; Bonadies N;
    Cancer Epidemiol; 2018 Feb; 52():55-62. PubMed ID: 29223104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukaemia in children: experience at a tertiary care facility of Pakistan.
    Fadoo Z; Mushtaq N; Alvi S; Ali M
    J Pak Med Assoc; 2012 Feb; 62(2):125-8. PubMed ID: 22755372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.